Tenax Therapeutics, Inc. TENX

1.81 (0.08) (4.23%) as of 25 Sep
Market cap
$70.0M
P/E
0.0×
Insider Buys alert about insiders buying in the last 12 month
Older periods Sep '25 Dec '25 Mar '26 Jun '26
ROE

+8 more TTM periods

(44.80%) (55.64%) (51.71%) (59.80%)
ROA
(42.77%) (52.36%) (49.23%) (57.02%)
ROIC
0.00% 0.00% 0.00% 0.00%
Return on Tangible Assets
(45.03%) (54.19%) (50.49%) (57.10%)
Average Days of Receivables
— — — —
Free Cash Flow per Share
(0.65) (0.91) (0.84) (0.90)
Free Cash Flow
(25.91) (35.80) (38.14) (46.03)
Other line items
Cash ROIC
(13.25%) (18.39%) (16.34%) (19.88%)
Accounts Payable Turnover
0.00 0.00 0.00 0.00
Average Days of Payables
0.00 0.00 0.00 0.00
Tax Rate
0.00 0.00 0.00 0.00
Research and Development Expense of Revenue
0.00% 0.00% 0.00% 0.00%
Selling, General and Administrative Expense of Revenue
0.00% 0.00% 0.00% 0.00%
Share Based Compensation of Revenue
— 0.00% 0.00% 0.00%
Interest Coverage
0.00 0.00 0.00 0.00
Operating CF/Net income
0.60 0.68 0.66 0.71
Depreciation/Fixed assets
0.00 — — —
Capex/Depreciation
0.00 — — —
Revenue per Share
0.00 0.00 0.00 0.00
Operating CF per Share
(0.65) (0.91) (0.84) (0.90)
Capex per Share
0.00 0.00 0.00 0.00
Net Profit Margin
0.00% 0.00% 0.00% 0.00%

Fold the line items

Columns are period end dates